TRANSCRIPTOMIC PUZZLE IN MYELODYSPLASTIC NEOPLASMS: UNRAVELING THE DISCORDANCE BETWEEN CD34+ STEM CELLS AND PRIMARY BONE MARROW CELLS

TRANSCRIPTOMIC PUZZLE IN MYELODYSPLASTIC NEOPLASMS: UNRAVELING THE DISCORDANCE BETWEEN CD34+ STEM CELLS AND PRIMARY BONE MARROW CELLS

Introduction: Differentially expressed genes (DEGs) biomarkers have the potential to aid in the diagnosis and monitoring of diseases, as well as determining the most effective treatments. However, due to the complex nature of Myelodysplastic neoplasm (MDS), it is challenging to assess the impact and...

Full description

Bibliographic Details
Main Authors:	HLR Junior, PG Gonçalves, DA Moreno, JVC Goes, RTG Oliveira, CV Montefusco-Pereira, MA Viana, TT Komoto, SMM Magalhães, RF Pinheiro
Format:	Article
Language:	English
Published:	Elsevier 2023-10-01
Series:	Hematology, Transfusion and Cell Therapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2531137923009811

Similar Items

THE ATAXIA-TELANGIECTASIA MUTATED (ATM) GENE PLAYS A PIVOTAL ROLE IN THE REPAIR OF DNA IN CASES OF MYELODYSPLASTIC NEOPLASM
by: JVC Goes, et al.
Published: (2024-10-01)

DIFFERENTIAL GENE EXPRESSION OF SIRTUINS (SIRT1 TO SIRT7) REVEALS POTENTIAL ROLES IN MYELODYSPLASTIC NEOPLASM PATHOBIOLOGY
by: JVC Goes, et al.
Published: (2023-10-01)

ASSESSMENT OF THE FEASIBILITY AND SAFETY OF ASSISTED CALORIC RESTRICTION (FMD) IN PATIENTS WITH MYELODYSPLASTIC NEOPLASMS
by: FJAB Ribeiro, et al.
Published: (2024-10-01)

RACIAL/ETHNIC DISPARITIES IN MYELODYSPLASTIC NEOPLASMS: CLINICAL CURRENT INSIGHTS AND FUTURE DIRECTIONS
by: JVC Goes, et al.
Published: (2024-10-01)

SCREENING OF ONCOGENIC VARIANTS IN DNA POLYMERASES WITH TRANSLESION SYNTHESIS ACTIVITY IN MYELODYSPLASTIC NEOPLASM
by: RTG Oliveira, et al.
Published: (2023-10-01)

HYPERMETHYLATION OF DNA REPAIR GENES IS LINKED TO PROGNOSIS OF MYELODYSPLASTIC NEOPLASM
by: MA Viana, et al.
Published: (2023-10-01)

NFKB, TRAF6, AND MYDDOSOME GENE EXPRESSION IN MYELODYSPLASTIC NEOPLASM (SMD) AND ACUTE MYELOID LEUKEMIA MYELODYSPLASIA RELATED (AML-MR)
by: AA Vieira, et al.
Published: (2024-10-01)

BEYOND OF MORPHOLOGY DIAGNOSIS: A CASE REPORT OF PIODERMA GANGRENOSO AS THE FIRST MANIFESTATION OF MYELODYSPLASTIC NEOPLASIA
by: NFAM Mendonça, et al.
Published: (2023-10-01)

TRENDS IN MYELODYSPLASTIC SYNDROMES-RELATED MORTALITY IN BRAZIL FROM 2014 TO 2023
by: PHV Moura, et al.
Published: (2024-10-01)

SJÖGREN-LARSSON SYNDROME ASSOCIATED WITH MYELODYSPLASTIC SYNDROME: A CASE REPORT
by: SCC Carneiro, et al.
Published: (2024-10-01)

BLASTING BEYOND THE OBVIOUS: IDENTIFICATION OF OVERLOOKED PREDICTIVE FACTORS FOR LEUKEMIC CONVERSION IN MYELODYSPLASTIC NEOPLASMS
by: PRC Passos, et al.
Published: (2024-10-01)

EXPRESSÃO DO RECEPTOR TOLL-LIKE 2 (TLR2), IRF7 E SERPINF COMO MARCADORES DE PROGNÓSTICO DESFAVORÁVEL EM PACIENTES COM SÍNDROME RESPIRATÓRIA AGUDA DECORRENTE DE INFECÇÃO POR COVID-19
by: DP Borges, et al.
Published: (2023-10-01)

Solving the puzzle of metastasis: the evolution of cell migration in neoplasms.
by: Jun Chen, et al.
Published: (2011-04-01)

NOVEL KEY VARIABLES IN THE SURVIVAL OF PATIENTS WITH MYELODYSPLASTIC NEOPLASMS: A PRACTICAL APPROACH USING MACHINE LEARNING
by: PRC Passos, et al.
Published: (2024-10-01)

Risk assessment in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms
by: Mario Cazzola
Published: (2011-03-01)

BLEACHING BODY HAIR CAN POTENTIALLY INCREASE THE RISK OF GENETIC INSTABILITY AND MYELOID NEOPLASMS
by: LR Sampaio, et al.
Published: (2024-10-01)

TRISOMY 8 IN HIGH RISK MDS PATIENT
by: AC Chaves, et al.
Published: (2023-10-01)

IS FERRITIN A GOOD PREDICTOR OF SURVIVAL ACROSS ALL RISK LEVELS IN MYELODYSPLASTIC NEOPLASMS? INSIGHTS FROM A STRATIFIED COHORT STUDY
by: PRC Passos, et al.
Published: (2024-10-01)

Unravelling the Chinese oil puzzle
by: Eckaus, Richard S.
Published: (2009)

Mitochondrial ataxia - Unravelling the puzzle
by: Neha Pandita, et al.
Published: (2024-05-01)

Single-cell transcriptomics dissects the transcriptome alterations of hematopoietic stem cells in myelodysplastic neoplasms
by: Xiangzong Zeng, et al.
Published: (2024-04-01)

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
by: Luca Malcovati, et al.
Published: (2014-11-01)

Analysing the evolutionary history of HCV: puzzle of ancient phylogenetic discordance.
by: Magiorkinis, G, et al.
Published: (2007)

Molecular basis of myelodysplastic/myeloproliferative neoplasms
by: Andreas Reiter, et al.
Published: (2009-12-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
by: Ziqi Wan, et al.
Published: (2020-10-01)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
by: Pellagatti, A, et al.
Published: (2008)

Elucidating the Role of the T Cell Receptor Repertoire in Myelodysplastic Neoplasms and Acute Myeloid Leukemia
by: Georgios Petros Barakos, et al.
Published: (2025-01-01)

Unraveling the diagnostic puzzle of eosinophilia in children
by: Elena Chiappini
Published: (2024-03-01)

Discordant Response of Systemic Mastocytosis Associated With Myelodysplastic Syndrome After Midostaurin and Allogeneic Hematopoietic Stem-cell Transplantation
by: Marion Haas, et al.
Published: (2020-12-01)

The immunobiology of myelodysplastic neoplasms: a mini-review
by: Shruthi Kannan, et al.
Published: (2024-09-01)

The immunoregulatory role of monocytes and thrombomodulin in myelodysplastic neoplasms
by: Luca L. G. Janssen, et al.
Published: (2024-07-01)

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
by: Thomas Ernst, et al.
Published: (2010-09-01)

Proteomics to predict relapse in patients with myelodysplastic neoplasms undergoing allogeneic hematopoietic cell transplantation
by: Guru Subramanian Guru Murthy, et al.
Published: (2024-01-01)

P738: EXPRESSION OF TRANSPOSABLE ELEMENTS IN CD34+ CELLS IN MYELODYSPLASTIC SYNDROMES
by: Z. Krejcik, et al.
Published: (2022-06-01)

Unravelling haematopoietic stem cell dysfunction in isolated Del(5q) myelodysplastic syndromes
by: Stenson, L
Published: (2015)

Unraveling the Puzzle: Oocyte Maturation Abnormalities (OMAS)
by: Safak Hatirnaz, et al.
Published: (2022-10-01)

Myelodysplastic Neoplasms (MDS): The Current and Future Treatment Landscape
by: Daniel Karel, et al.
Published: (2024-04-01)

A Brief Overview of the Molecular Landscape of Myelodysplastic Neoplasms
by: Rami Abdulbaki, et al.
Published: (2024-04-01)

Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
by: Josephine Lucero, et al.
Published: (2023-06-01)

CONTRIBUTION OF SOMATIC MUTATIONS IN THE RISK STRATIFICATION OF MYELODYSPLASTIC NEOPLASMS
by: FK Marques, et al.
Published: (2023-10-01)